NCT04879654

Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of SNMM After Endoscopic Surgery

Phase II, Single-arm, Prospective Clinical Study of Toripalimab Combined With Radiotherapy and Chemotherapy in the Treatment of Sinonasal Malignant Mucosal Melanoma（SNMM） After Endoscopic Surgery

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 45 (estimated)
• Sponsor: Eye & ENT Hospital of Fudan University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Phase II, single-arm, prospective clinical study of Toripalimab(a PD-1 antibody) combined with radiotherapy and chemotherapy in the treatment of sinonasal malignant mucosal melanoma after endoscopic surgery.

Conditions

• Malignant Melanoma
• Sinonasal Melanoma

Interventions

Type	Name	Description
PROCEDURE	endoscopic surgery	endoscopic surgery followed by multimodality treatment including radiotherapy,Toripalimab,and/or chemotherapy

Timeline

• Start date: 2021-05-01
• Primary completion: 2026-05-01
• Completion: 2026-05-01
• First posted: 2021-05-10
• Last updated: 2024-03-05

Locations

1 site across 1 country: China